Strategic Partnerships Recent licensing and distribution partnerships with Lipocine in the US and Canada, and Cumberland Pharmaceuticals in Puerto Rico, indicate Verity’s openness to co-marketing and regional expansion. Sales outreach can target co-branding opportunities, cross-sell complementary therapies, and leverage these alliances to accelerate market access for scarce or absent therapies.

canadian focus As a Canada-based specialty pharma focused on therapies in short supply or absent from the Canadian healthcare system, Verity presents a primary opportunity to expand physician and hospital formularies, negotiate reimbursement pathways, and secure inclusion for high-need therapeutics in provincial pharmacare programs.

Therapeutic Scarcity Verity targets therapeutically relevant prescription medicines that are in short supply. This creates demand for strategic account management with key Canadian health authorities, hospital networks, and specialty pharmacies, offering upsell opportunities around inventory risk management and rapid access programs.

Market Position Operating with an experienced leadership team and a global scientific advisory board, Verity can be positioned as a trusted partner for specialty products. Sales efforts can emphasize clinical value, real-world outcomes, and evidence generation to support formulary adoption and expansion across Canada.

Expansion Readiness Partnerships indicate readiness for selective geographic and product expansion. Nuanced outreach can target additional markets with similar supply gaps, identify co-development or license opportunities for missed therapies, and propose joint market access plans to accelerate launches.